APO Research
Talk to an analyst

APO RESEARCH · REPORT

Self-replicating mRNA Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Self-replicating mRNA Vaccines Industry Research Report 2026

27 December 2025128 pages

Choose your research edition.

Industry ResearchSelf-replicating mRNA Vaccines Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Self-replicating mRNA Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Self-replicating mRNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Self-replicating mRNA Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Self-replicating mRNA Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Self-replicating mRNA Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Self-replicating mRNA Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Self-replicating mRNA Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Self-replicating mRNA Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Self-replicating mRNA Vaccines include Aldevron, Arcturus Therapeutics, BioNTech, Chimeron Bio, CSL, Elixirgen Therapeutics, Gritstone Bio, Precision Nanosystems and Replicate Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Self-replicating mRNA Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Self-replicating mRNA Vaccines Market by Company

Aldevron

Arcturus Therapeutics

BioNTech

Chimeron Bio

CSL

Elixirgen Therapeutics

Gritstone Bio

Precision Nanosystems

Replicate Bioscience

VaxEquity

Ziphius Vaccines

GSK

Immorna

Self-replicating mRNA Vaccines Segment by Type

Preventive Medicine

Medicine

Self-replicating mRNA Vaccines Segment by Application

Infectious Disease

Cancer

Others

Self-replicating mRNA Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self-replicating mRNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Self-replicating mRNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self-replicating mRNA Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Self-replicating mRNA Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Self-replicating mRNA Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Self-replicating mRNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Self-replicating mRNA Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Self-replicating mRNA Vaccines Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Self-replicating mRNA Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Self-replicating mRNA Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Self-replicating mRNA Vaccines Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Self-replicating mRNA Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Self-replicating mRNA Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Self-replicating mRNA Vaccines, Product Type & Application Table 14. Global Self-replicating mRNA Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Self-replicating mRNA Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Aldevron Company Information Table 19. Aldevron Business Overview Table 20. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Aldevron Self-replicating mRNA Vaccines Product Portfolio Table 22. Aldevron Recent Developments Table 23. Arcturus Therapeutics Company Information Table 24. Arcturus Therapeutics Business Overview Table 25. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 27. Arcturus Therapeutics Recent Developments Table 28. BioNTech Company Information Table 29. BioNTech Business Overview Table 30. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. BioNTech Self-replicating mRNA Vaccines Product Portfolio Table 32. BioNTech Recent Developments Table 33. Chimeron Bio Company Information Table 34. Chimeron Bio Business Overview Table 35. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio Table 37. Chimeron Bio Recent Developments Table 38. CSL Company Information Table 39. CSL Business Overview Table 40. CSL Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. CSL Self-replicating mRNA Vaccines Product Portfolio Table 42. CSL Recent Developments Table 43. Elixirgen Therapeutics Company Information Table 44. Elixirgen Therapeutics Business Overview Table 45. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 47. Elixirgen Therapeutics Recent Developments Table 48. Gritstone Bio Company Information Table 49. Gritstone Bio Business Overview Table 50. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio Table 52. Gritstone Bio Recent Developments Table 53. Precision Nanosystems Company Information Table 54. Precision Nanosystems Business Overview Table 55. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio Table 57. Precision Nanosystems Recent Developments Table 58. Replicate Bioscience Company Information Table 59. Replicate Bioscience Business Overview Table 60. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio Table 62. Replicate Bioscience Recent Developments Table 63. VaxEquity Company Information Table 64. VaxEquity Business Overview Table 65. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. VaxEquity Self-replicating mRNA Vaccines Product Portfolio Table 67. VaxEquity Recent Developments Table 68. Ziphius Vaccines Company Information Table 69. Ziphius Vaccines Business Overview Table 70. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio Table 72. Ziphius Vaccines Recent Developments Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GSK Self-replicating mRNA Vaccines Product Portfolio Table 77. GSK Recent Developments Table 78. Immorna Company Information Table 79. Immorna Business Overview Table 80. Immorna Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Immorna Self-replicating mRNA Vaccines Product Portfolio Table 82. Immorna Recent Developments Table 83. Global Self-replicating mRNA Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Self-replicating mRNA Vaccines Sales by Region (2021-2026) & (K Units) Table 85. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2021-2026) Table 86. Global Self-replicating mRNA Vaccines Sales by Region (2027-2032) & (K Units) Table 87. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2027-2032) Table 88. Global Self-replicating mRNA Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2021-2026) Table 90. Global Self-replicating mRNA Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2027-2032) Table 92. North America Self-replicating mRNA Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 94. North America Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 95. North America Self-replicating mRNA Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Self-replicating mRNA Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Self-replicating mRNA Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 99. Europe Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 100. Europe Self-replicating mRNA Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Self-replicating mRNA Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Self-replicating mRNA Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 104. Asia Pacific Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 105. Asia Pacific Self-replicating mRNA Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Self-replicating mRNA Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Self-replicating mRNA Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 109. South America Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 110. South America Self-replicating mRNA Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Self-replicating mRNA Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 114. Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 115. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 118. Global Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 119. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2026) Table 120. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2027-2032) Table 121. Global Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2026) Table 124. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2027-2032) Table 125. Global Self-replicating mRNA Vaccines Price by Type (2021-2026) & (US$/Unit) Table 126. Global Self-replicating mRNA Vaccines Price by Type (2027-2032) & (US$/Unit) Table 127. Global Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 128. Global Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 129. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2026) Table 130. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2027-2032) Table 131. Global Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2026) Table 134. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2027-2032) Table 135. Global Self-replicating mRNA Vaccines Price by Application (2021-2026) & (US$/Unit) Table 136. Global Self-replicating mRNA Vaccines Price by Application (2027-2032) & (US$/Unit) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Self-replicating mRNA Vaccines Distributors List Table 140. Self-replicating mRNA Vaccines Customers List Table 141. Self-replicating mRNA Vaccines Industry Trends Table 142. Self-replicating mRNA Vaccines Industry Drivers Table 143. Self-replicating mRNA Vaccines Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Self-replicating mRNA Vaccines Product Image Figure 5. Global Self-replicating mRNA Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Self-replicating mRNA Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Self-replicating mRNA Vaccines Sales (2021-2032) & (K Units) Figure 8. Global Self-replicating mRNA Vaccines Average Price (US$/Unit) & (2021-2032) Figure 9. Preventive Medicine Product Image Figure 10. Medicine Product Image Figure 11. Infectious Disease Product Image Figure 12. Cancer Product Image Figure 13. Others Product Image Figure 14. Global Self-replicating mRNA Vaccines Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Self-replicating mRNA Vaccines, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Self-replicating mRNA Vaccines Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Self-replicating mRNA Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Self-replicating mRNA Vaccines Sales by Region in 2025 Figure 20. Global Self-replicating mRNA Vaccines Revenue by Region in 2025 Figure 21. North America Self-replicating mRNA Vaccines Market Size by Country in 2025 Figure 22. North America Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 23. North America Self-replicating mRNA Vaccines Revenue Market Share by Country (2021-2032) Figure 24. United States Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Self-replicating mRNA Vaccines Market Size by Country in 2025 Figure 28. Europe Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 29. Europe Self-replicating mRNA Vaccines Revenue Market Share by Country (2021-2032) Figure 30. Germany Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Self-replicating mRNA Vaccines Market Size by Country in 2025 Figure 41. Asia Pacific Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Self-replicating mRNA Vaccines Revenue Market Share by Country (2021-2032) Figure 43. China Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Self-replicating mRNA Vaccines Market Size by Country in 2025 Figure 52. South America Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 53. South America Self-replicating mRNA Vaccines Revenue Market Share by Country (2021-2032) Figure 54. Brazil Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country in 2025 Figure 58. Middle East and Africa Self-replicating mRNA Vaccines Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Self-replicating mRNA Vaccines Revenue Market Share by Country (2021-2032) Figure 60. Egypt Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Self-replicating mRNA Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2032) Figure 66. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2032) Figure 67. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Type (2021-2032) Figure 68. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2032) Figure 69. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2032) Figure 70. Global Self-replicating mRNA Vaccines Price (US$/Unit) by Application (2021-2032) Figure 71. Self-replicating mRNA Vaccines Value Chain Figure 72. Self-replicating mRNA Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Self-replicating mRNA Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Preventive Medicine
  • Medicine
Applications
  • Infectious Disease
  • Cancer
  • Others
Companies covered
  • Aldevron
  • Arcturus Therapeutics
  • BioNTech
  • Chimeron Bio
  • CSL
  • Elixirgen Therapeutics
  • Gritstone Bio
  • Precision Nanosystems
  • Replicate Bioscience
  • VaxEquity
  • Ziphius Vaccines
  • GSK
  • Immorna

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Self-replicating mRNA Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Self-replicating mRNA Vaccines Sales (2021-2032)
  5. 2.2.3 Global Self-replicating mRNA Vaccines Market Average Price (2021-2032)
  6. 2.3 Self-replicating mRNA Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Preventive Medicine
  9. 2.3.3 Medicine
  10. 2.4 Self-replicating mRNA Vaccines by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Infectious Disease
  13. 2.4.3 Cancer
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Self-replicating mRNA Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Self-replicating mRNA Vaccines Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Self-replicating mRNA Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Self-replicating mRNA Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Self-replicating mRNA Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Self-replicating mRNA Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Self-replicating mRNA Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Self-replicating mRNA Vaccines, Established Date
  9. 3.9 Global Self-replicating mRNA Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Aldevron
  2. 4.1.1 Aldevron Company Information
  3. 4.1.2 Aldevron Business Overview
  4. 4.1.3 Aldevron Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Aldevron Self-replicating mRNA Vaccines Product Portfolio
  6. 4.1.5 Aldevron Recent Developments
  7. 4.2 Arcturus Therapeutics
  8. 4.2.1 Arcturus Therapeutics Company Information
  9. 4.2.2 Arcturus Therapeutics Business Overview
  10. 4.2.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  12. 4.2.5 Arcturus Therapeutics Recent Developments
  13. 4.3 BioNTech
  14. 4.3.1 BioNTech Company Information
  15. 4.3.2 BioNTech Business Overview
  16. 4.3.3 BioNTech Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 BioNTech Self-replicating mRNA Vaccines Product Portfolio
  18. 4.3.5 BioNTech Recent Developments
  19. 4.4 Chimeron Bio
  20. 4.4.1 Chimeron Bio Company Information
  21. 4.4.2 Chimeron Bio Business Overview
  22. 4.4.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio
  24. 4.4.5 Chimeron Bio Recent Developments
  25. 4.5 CSL
  26. 4.5.1 CSL Company Information
  27. 4.5.2 CSL Business Overview
  28. 4.5.3 CSL Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CSL Self-replicating mRNA Vaccines Product Portfolio
  30. 4.5.5 CSL Recent Developments
  31. 4.6 Elixirgen Therapeutics
  32. 4.6.1 Elixirgen Therapeutics Company Information
  33. 4.6.2 Elixirgen Therapeutics Business Overview
  34. 4.6.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  36. 4.6.5 Elixirgen Therapeutics Recent Developments
  37. 4.7 Gritstone Bio
  38. 4.7.1 Gritstone Bio Company Information
  39. 4.7.2 Gritstone Bio Business Overview
  40. 4.7.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio
  42. 4.7.5 Gritstone Bio Recent Developments
  43. 4.8 Precision Nanosystems
  44. 4.8.1 Precision Nanosystems Company Information
  45. 4.8.2 Precision Nanosystems Business Overview
  46. 4.8.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio
  48. 4.8.5 Precision Nanosystems Recent Developments
  49. 4.9 Replicate Bioscience
  50. 4.9.1 Replicate Bioscience Company Information
  51. 4.9.2 Replicate Bioscience Business Overview
  52. 4.9.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio
  54. 4.9.5 Replicate Bioscience Recent Developments
  55. 4.10 VaxEquity
  56. 4.10.1 VaxEquity Company Information
  57. 4.10.2 VaxEquity Business Overview
  58. 4.10.3 VaxEquity Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 VaxEquity Self-replicating mRNA Vaccines Product Portfolio
  60. 4.10.5 VaxEquity Recent Developments
  61. 4.11 Ziphius Vaccines
  62. 4.11.1 Ziphius Vaccines Company Information
  63. 4.11.2 Ziphius Vaccines Business Overview
  64. 4.11.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio
  66. 4.11.5 Ziphius Vaccines Recent Developments
  67. 4.12 GSK
  68. 4.12.1 GSK Company Information
  69. 4.12.2 GSK Business Overview
  70. 4.12.3 GSK Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 GSK Self-replicating mRNA Vaccines Product Portfolio
  72. 4.12.5 GSK Recent Developments
  73. 4.13 Immorna
  74. 4.13.1 Immorna Company Information
  75. 4.13.2 Immorna Business Overview
  76. 4.13.3 Immorna Self-replicating mRNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Immorna Self-replicating mRNA Vaccines Product Portfolio
  78. 4.13.5 Immorna Recent Developments
5 Global Self-replicating mRNA Vaccines Market Scenario by Region
  1. 5.1 Global Self-replicating mRNA Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Self-replicating mRNA Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Self-replicating mRNA Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Self-replicating mRNA Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Self-replicating mRNA Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Self-replicating mRNA Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Self-replicating mRNA Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Self-replicating mRNA Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Self-replicating mRNA Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Self-replicating mRNA Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Self-replicating mRNA Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Self-replicating mRNA Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Self-replicating mRNA Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Self-replicating mRNA Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Self-replicating mRNA Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Self-replicating mRNA Vaccines Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Self-replicating mRNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Self-replicating mRNA Vaccines Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Self-replicating mRNA Vaccines Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Self-replicating mRNA Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Self-replicating mRNA Vaccines Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Self-replicating mRNA Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Self-replicating mRNA Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Self-replicating mRNA Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Self-replicating mRNA Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Self-replicating mRNA Vaccines Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Self-replicating mRNA Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Self-replicating mRNA Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Self-replicating mRNA Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Self-replicating mRNA Vaccines Value Chain Analysis
  2. 8.1.1 Self-replicating mRNA Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Self-replicating mRNA Vaccines Production Mode & Process
  5. 8.2 Self-replicating mRNA Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Self-replicating mRNA Vaccines Distributors
  8. 8.2.3 Self-replicating mRNA Vaccines Customers
9 Global Self-replicating mRNA Vaccines Analyzing Market Dynamics
  1. 9.1 Self-replicating mRNA Vaccines Industry Trends
  2. 9.2 Self-replicating mRNA Vaccines Industry Drivers
  3. 9.3 Self-replicating mRNA Vaccines Industry Opportunities and Challenges
  4. 9.4 Self-replicating mRNA Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst